Predicting Immunotherapy Response, Melanoma
January 17, 2023 | Terry Sharrer
Researchers “from the Johns Hopkins Kimmel Comprehensive Cancer Center and its Bloomberg Kimmel Institute for Cancer Immunotherapy report that their novel machine learning algorithm helps predict which patients with melanoma would respond to treatment and which would not respond. The open-source program, DeepTCR, proved valuable as a predictive clinical tool, but it also helped teach the researchers about the biological mechanisms underlying patients’ responses to immunotherapy. Their findings are published in the journal Science Advances.” MORE
Image Credit: AdobeStacks and John Hopkins Medicine Newsroom